Sunday, February 22, 2026 | 06:02 AM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

Anjali Singh

Anjali Singh

Anjali Singh

Anjali Singh covers the automobile and pharmaceutical sectors, focusing on trends, policy developments, regulatory changes, industry expectations, corporate results among others. A postgraduate in communication journalism, she has a strong inclination towards data-driven reporting and enjoys breaking down complex topics to make them interesting and relevant for readers.

Anjali Singh covers the automobile and pharmaceutical sectors, focusing on trends, policy developments, regulatory changes, industry expectations, corporate results among others. A postgraduate in communication journalism, she has a strong inclination towards data-driven reporting and enjoys breaking down complex topics to make them interesting and relevant for readers.

Email
Twitter
LinkedIn

Page 12 - Anjali Singh

CDMOs gear up for peptide boom amid rising demand for weight-loss drugs

With global demand for GLP-1-based drugs rising, Indian CDMOs are ramping up peptide capabilities ahead of key patent expiries such as that of semaglutide in 2026

CDMOs gear up for peptide boom amid rising demand for weight-loss drugs
Updated On : 24 Jul 2025 | 11:47 PM IST

Sun Pharma's psoriasis drug delivers positive results in arthritis trials

Sun Pharma's psoriasis drug Ilumya shows promising results in late-stage psoriatic arthritis trials, paving the way for potential regulatory filings and expansion into the immunology market.

Sun Pharma's psoriasis drug delivers positive results in arthritis trials
Updated On : 21 Jul 2025 | 5:44 PM IST

Tyre industry to grow 7-8% in FY26, driven by replacement demand: Crisil

Crisil expects India's Rs 1 trillion tyre industry to grow 7-8% in FY26, mainly driven by replacement demand, while OEM volumes and global trade risks continue to pose challenges

Tyre industry to grow 7-8% in FY26, driven by replacement demand: Crisil
Updated On : 18 Jul 2025 | 4:08 PM IST

CORONA Remedies acquires 7 pharma brands from Bayer India, plans expansion

CORONA Remedies deepens footprint in women's healthcare and cardiology with Bayer India portfolio acquisition, entering anti-platelet and hormone therapy segments

CORONA Remedies acquires 7 pharma brands from Bayer India, plans expansion
Updated On : 17 Jul 2025 | 10:02 PM IST

Ceat Q1FY26: Profit declines 27% on higher costs, revenue rises 10.5%

Ceat Q1 net profit declines 27 per cent due to IPL-linked marketing spends and higher input costs even as revenue rises 10.5 per cent on strong OEM and replacement demand

Ceat Q1FY26: Profit declines 27% on higher costs, revenue rises 10.5%
Updated On : 17 Jul 2025 | 8:37 PM IST

Curtains rise today on Tesla's India foray; Model Y tipped as flagbearer

Real estate analysts watching Tesla's impact on rentals closely

Curtains rise today on Tesla's India foray; Model Y tipped as flagbearer
Updated On : 15 Jul 2025 | 12:01 AM IST

Temasek's India exposure hits $50 bn, eyes $3-4 bn annual investments

Temasek Holdings increases its India exposure to $50 billion by March 2025, with plans to invest $3-4 billion annually, focusing on sectors like financial services, healthcare, and sustainability

Temasek's India exposure hits $50 bn, eyes $3-4 bn annual investments
Updated On : 14 Jul 2025 | 11:12 PM IST

UK company AEM set to bring rare-earth-free technology to India

The firm has partnered with Sterling Tools Limited's EV arm, Sterling Gtake Electro Mobility (SGEM), to localise production and assembly of its traction motors at SGEM's Faridabad facility

UK company AEM set to bring rare-earth-free technology to India
Updated On : 11 Jul 2025 | 10:22 PM IST

Used-car sales to expand 8-10% in FY26, outpace new vehicles: Crisil

The used-to-new car sales ratio has increased to 1.4 from less than 1 five years ago. The market value of these used cars is estimated to be around Rs 4 trillion, nearly matching that of new car sales

Used-car sales to expand 8-10% in FY26, outpace new vehicles: Crisil
Updated On : 11 Jul 2025 | 2:46 PM IST

Glenmark arm inks $700 million licensing deal with US-based AbbVie

IGI Therapeutics, a wholly owned subsidiary of Glenmark, has licensed its cancer and autoimmune drug ISB 2001 to AbbVie for an upfront payment of $700 million

Glenmark arm inks $700 million licensing deal with US-based AbbVie
Updated On : 10 Jul 2025 | 11:21 PM IST

Daimler Truck targets over 60,000 units to scale up operations by 2030

India to become a strategic base for Daimler Truck's global operations in manufacturing, R&D and exports under its Unlock Full Potential transformation plan

Daimler Truck targets over 60,000 units to scale up operations by 2030
Updated On : 09 Jul 2025 | 11:28 PM IST

Anthem Biosciences expands manufacturing capacity ahead of ₹3,395-cr IPO

CRDMO firm Anthem Biosciences expands peptide and API production, with Unit 4 under development, as it prepares for a Rs 3,395-crore IPO opening on July 14

Anthem Biosciences expands manufacturing capacity ahead of ₹3,395-cr IPO
Updated On : 09 Jul 2025 | 8:41 PM IST

India's electric vehicle sales surged in June; slow start for e2Ws: Fada

India's EV market continued to expand in June 2025, with a notable rise in passenger vehicle sales. However, the two-wheeler segment saw a dip in H1 performance due to a weak start to the year

India's electric vehicle sales surged in June; slow start for e2Ws: Fada
Updated On : 08 Jul 2025 | 11:06 PM IST

Tata Motors' global wholesales fall 9% in Q1, led by JLR and PV segments

Tata Motors Group's global wholesales fell 9% YoY in Q1 FY26, reaching 2,99,664 units, with declines in both commercial and passenger vehicles, including Jaguar Land Rover (JLR).

Tata Motors' global wholesales fall 9% in Q1, led by JLR and PV segments
Updated On : 08 Jul 2025 | 7:33 PM IST

JLR reports Q1 sales decline due to Jaguar phase-out and US tariffs

Jaguar Land Rover (JLR) reports a 10.7% drop in Q1 FY26 wholesale volumes and 15.1% decline in retail sales, citing the Jaguar phase-out and US import tariffs as major factors.

JLR reports Q1 sales decline due to Jaguar phase-out and US tariffs
Updated On : 07 Jul 2025 | 10:28 PM IST

OLX India launches Elite Buyer plan to improve second-hand deals

The subscription-based Elite Buyer Program gives users category-specific tags and verified leads to speed up responses and boost trust in second-hand transactions

OLX India launches Elite Buyer plan to improve second-hand deals
Updated On : 07 Jul 2025 | 7:55 PM IST

Skoda Auto Volkswagen India to manage Bentley operations from July 2025

SAVWIPL becomes Bentley's exclusive importer and distributor in India from July 2025, establishing Bentley India and expanding its luxury portfolio in the country

Skoda Auto Volkswagen India to manage Bentley operations from July 2025
Updated On : 07 Jul 2025 | 7:01 PM IST

Steep car discounts mark H1, two-wheeler sales hold firm in rural India

Passenger vehicle makers are offering deep discounts to clear unsold 2024 stock, while two-wheeler companies stay cautious amid steady demand and manageable inventories

Steep car discounts mark H1, two-wheeler sales hold firm in rural India
Updated On : 07 Jul 2025 | 12:05 AM IST

Price pressures to intensify for drugmakers, says Sun Pharmaceutical

Sun Pharma expects global pricing strain due to policy shifts, as FY25 US sales rise 5.8% despite compliance challenges; specialty business lifts overall growth

Price pressures to intensify for drugmakers, says Sun Pharmaceutical
Updated On : 04 Jul 2025 | 8:22 PM IST

Mahindra BE 6, XEV 9e Pack Two EV deliveries to start by July-end

BE 6 and XEV 9e Pack Two models to feature a new 79 kWh battery option with a 500 km range, Level 2 ADAS, fast charging and expanded connected car features

Mahindra BE 6, XEV 9e Pack Two EV deliveries to start by July-end
Updated On : 04 Jul 2025 | 7:39 PM IST